New technologies and adaptations of existing technologies can improve platform processes.
Judy Glynn
Advertisement
Judy Glynn is senior principal scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles by Judy Glynn
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
If certain engineering challenges can be addressed, precipitation may prove to be a valuable tool for antibody purification.
Advertisement
Latest Updated Articles
Advances in Monoclonal Antibody PurificationPublished: March 2nd 2010 | Updated:
The Development and Application of a Monoclonal Antibody Purification PlatformPublished: October 2nd 2009 | Updated:
The Development and Application of a Monoclonal Antibody Purification PlatformPublished: March 2nd 2009 | Updated:
Process-Scale Precipitation of Impurities in Mammalian Cell Culture BrothPublished: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
Welcome to CPHI Frankfurt 2025
4
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
5
